SARS CoV 2 News and Research

RSS

A road map to find unanswered questions about COVID-19

There are many unanswered questions about COVID-19. A Kansas State University infectious disease scientist and collaborators are offering a possible research road map to find the answers.

15 May 2020

Antiviral agent accelerates virus clearance in cases of COVID-19

A team of researchers from have found an antiviral therapy that seems to be an effective treatment for patients with moderate coronavirus disease 2019 (COVID-19).

15 May 2020

COVID-19 and food insecurity in the U.S.

A new paper published on the preprint server medRxiv* in May 2020 reports that the measures taken to block the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) such as social distancing and lockdown are associated with widespread effects on food security in the US state of Vermont.

14 May 2020

SARS-CoV-2 will infect 250 million people in Africa

A study conducted by the World Health Organization (WHO) has predicted that the coronavirus will infect almost one-quarter of a billion people in Africa during the first year of the pandemic. Unless immediate measures are taken to control the spread of the virus, as many as 190,000 of them are likely to die, the researchers warn.

14 May 2020

New insights into SARS-CoV-2 viral diversity

The first comprehensive, large-scale analysis available on the preprint server bioRxiv attempted to identify specific genomic signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains within and across individual hosts – revealing recombination events, specific geographic profiles, as well as multi-strain and/or superinfections characteristic for the coronavirus disease (COVID-19) pandemic.

14 May 2020

Continuously active antiviral coating may reduce the spread of COVID-19

Surfaces coated with a quaternary ammonium polymer have remarkable antiviral properties. They may even be capable of reducing the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in areas with high risk for contamination, such as indoor environments or public places. University of Arizona researchers explain the antiviral potential of these in a new study published on the preprint server medRxiv.

14 May 2020

NIH begins clinical study to evaluate hydroxychloroquine and azithromycin for COVID-19

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19).

14 May 2020

New clinical trial to investigate the efficacy of ivermectin against COVID-19

Clínica Universidad de Navarra and the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, have launched a clinical trial to investigate the efficacy of ivermectin against COVID-19.

14 May 2020

Rice engineer receives NSF grant to study effect of varying temperatures on coronavirus

Daniel Preston, an assistant professor of mechanical engineering at Rice's Brown School of Engineering, has received a National Science Foundation Rapid Response Research grant to study the effect of varying temperatures on the lifetime of the virus responsible for the COVID-19 pandemic.

14 May 2020

ACTG initiates clinical trial to evaluate treatment for COVID-19

The AIDS Clinical Trials Group, the world's largest and longest established HIV research network, today announced the initiation of ACTG 5395, a clinical trial to evaluate whether the drug combination hydroxychloroquine and azithromycin can prevent hospitalization and death from COVID-19 (which is caused by infection with the virus SARS-CoV-2).

14 May 2020

Low-cost PCR test designed to detect coronavirus

The project of Consuelo Rubio has been among those chosen for the call of the Valencian System of Innovation and Research for the COVID-19 emergency.

14 May 2020

Masks made from simple fabric offer limited protection, say experts

Ensuring the protection of people's health and lives, especially in respirators and personal protective equipment (PPE) for use by health care personnel, has been one of the essential premises since the Artefactos community began to design and manufacture adaptations with which to face Covid-19.

14 May 2020

Potential targets discovered for COVID-19 therapy

A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-2, the virus causing COVID-19 in people.

14 May 2020

About 4.4% of French population had been infected with SARS-CoV-2, suggests study

By 11 May, when lockdown restrictions were eased in France, about 4.4% of the French population had been infected with SARS-CoV-2, a new modeling study suggests.

14 May 2020

Study finds no evidence of COVID-19 virus transmitting from cats to humans

Three cats infected with the virus that causes COVID-19 spread the virus to three other cats in a lab study published in The New England Journal of Medicine by a research team working in Tokyo, Japan, and Wisconsin, USA.

14 May 2020

New research and guidance focus on critical health aspects during COVID-19 epidemic

New research and guidance in the American Journal of Preventive Medicine, published by Elsevier, focus on critical topics pertaining to community and individual health during the COVID-19 epidemic.

14 May 2020

Visual Science designs a scientific model of SARS-Cov-2 virus

The biomedical visualization studio Visual Science has created the most detailed and scientifically accurate 3D model of the full SARS-CoV-2 virus at atomic resolution.

14 May 2020

Cats can readily become infected with SARS-CoV-2, confirms study

In a study published today (May 13, 2020) in the New England Journal of Medicine, scientists in the U.S. and Japan report that in the laboratory, cats can readily become infected with SARS-CoV-2, the virus that causes COVID-19, and may be able to pass the virus to other cats.

14 May 2020

New textile coating prevents viruses from adhering to the surface

Masks, gowns, and other personal protective equipment (PPE) are essential for protecting healthcare workers. However, the textiles and materials used in such items can absorb and carry viruses and bacteria, inadvertently spreading the disease the wearer sought to contain.

14 May 2020

New program developed to support the lifting of Covid-19 restrictions

To support a smooth lifting of restrictions to inhibit the spread of COVID-19, the Research Luxembourg COVID-19 Task Force has developed a "Proactive Mitigation Programme" based on a voluntary diagnostic test accessible to the population, including cross-border workers.

14 May 2020